Results 11 to 20 of about 452,734 (338)

Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination. [PDF]

PLoS ONE, 2016
To compare the safety and efficacy of fixed-dose tafluprost/timolol combination (Taf/T-FDC) with those of fixed-dose latanoprost/timolol combination (Lat/T-FDC) by measuring the intraocular pressure (IOP)-lowering effect, ocular pharmacokinetics, and ...
Masahiro Fuwa, Kenji Ueda, Takahiro Akaishi, Naoko Yamashita, Tomoko Kirihara, Atsushi Shimazaki, Hidetoshi Mano, Kouichi Kawazu   +7 more
doaj   +4 more sources

Fixed-dose combination antihypertensive medications. [PDF]

The Lancet, 2019
IJB is President of the American Heart Association. RK is Secretary of the European Society of Hypertension. MHO is a member of the Lancet Commission on hypertension. AES is President of the International Society of Hypertension. PL-J is President of the
Ivor J. Benjamin, R. Kreutz, M. Olsen, A. Schutte, P. López-Jaramillo, T. Frieden, K. Sliwa, D. Lackland, M. Brainin   +8 more
semanticscholar   +7 more sources

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes

Diabetes, Metabolic Syndrome and Obesity, 2009
Jonathan K ReynoldsWashington State University, College of Pharmacy, Pullman, WA, USAAbstract: JanumetTM, a fixed dose combination of sitagliptin/metformin HCL manufactured by Merck Pharmaceuticals, has received US Food and Drug Administration approval ...
Jonathan K Reynolds
doaj   +1 more source

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects

Drug Design, Development and Therapy, 2019
Minkyung Oh,1 Jae-Gook Shin,1,2 Sangzin Ahn,1 Bo Hoon Kim,3 Ji Yeon Kim,3 Hyun Ju Shin,4 Hyun Ju Shin,4 Jong-Lyul Ghim1,21Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea ...
Oh M, Shin JG, Ahn S, Kim BH, Kim JY, Shin HJ, Shin HJ, Ghim JL   +7 more
doaj   +1 more source

Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Hypertension and hypercholesterolemia are important risk factors for cardiovascular disease, and treatment with fixed‐dose combination (FDC) regimens is recommended by current guidelines. However, the clinical outcomes of different FDC dosages
Chia‐Pin Lin, Tzyy‐Jer Hsu, Ying‐Chang Tung, Fu‐Chih Hsiao, Shing‐Hsien Chou, Yu‐Sheng Lin, Shao‐Wei Chen, Pao‐Hsien Chu   +7 more
doaj   +3 more sources

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic

Vascular Health and Risk Management, 2012
Massimo Volpe,1,2 Giuliano Tocci21Division of Cardiology, Department of Clinical and Molecular Medicine, University of Rome, Sapienza, Sant'Andrea Hospital, Rome, 2IRCCS Neuromed, Pozzilli, ItalyAbstract: Hypertension is a growing global health ...
Volpe M, Tocci G
doaj   +3 more sources

From combined therapy to fixed-dose combinations

Кардиоваскулярная терапия и профилактика, 2008
Due to low effectiveness of arterial hypertension (AH) monotherapy, recent debates have concentrated on evidence-based effectiveness and safety of combined AH therapy.
I. P. Kolos, S. A. Boytsov
doaj   +1 more source

Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects

Фармакокинетика и Фармакодинамика, 2022
Introduction. The advantages of fixed-dose combination losartan + amlodipine + rosuvastatin compared to mono-drugs and two-component combinations are to increase the therapeutic efficacy, to reduce the cost of the product and to make the drug easier to ...
A. L. Khokhlov, D. Yu. Grebenkin, E. K. Faeva, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva   +6 more
doaj   +1 more source

Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice

Vascular Health and Risk Management, 2010
Peter Bramlage1, Wolf-Peter Wolf2, Thomas Stuhr2, Eva-Maria Fronk3, Wolfhard Erdlenbruch2, Reinhard Ketelhut4, Roland E Schmieder51Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow; 2Daiichi Sankyo Deutschland GmbH, Munich, Germany ...
Peter Bramlage, Wolf-Peter Wolf, Thomas Stuhr, et al   +3 more
doaj   +1 more source

Fixed-dose Combination Therapy in Hypertension: Focus on Fixed-dose combination of Amlodipine and Valsartan (Exforge®) [PDF]

Clinical Medicine. Therapeutics, 2009
Hypertension is the leading cause of disability and cardiovascular mortality world-wide. Approximately one-third of the US adult population and over a billion people world-wide have hypertension.
Shakil Aslam
core   +2 more sources